儿科

Accelerating the development of safe and effective treatments for children and adolescents

Leverage our deep understanding of the diverse populations—spanning preterm infants to adolescents—to guide your pediatric research.

Address the needs of pediatric patients and their families across your development journey with our extensive regulatory, medical and operational expertise.

Speed up your pediatric drug development plan with our best practices to efficiently enroll adolescents and young adult populations into your pivotal trials.

Pediatric patients and their families are at the center of all we do.

Participating in a pediatric trial requires a huge commitment not just from a patient, but also their family. That's why our pediatric experts at Fortrea work to develop tailored solutions that address specific study considerations, minimize the burden of the participation and support successful study conduct.

At Fortrea, we share your passion to make a difference in patients' lives. You'll get a partner that:

Understands the nuances of pediatric research
Offers longstanding experience designing, planning and conducting pediatric programs
Delivers the collective knowledge of 34 pediatricians and more than 2,400 employees experienced with pediatric populations

Together, let’s address the inherent challenges of pediatric studies and navigate the best path ahead.

选择合作伙伴时，经验很重要

让我们共同探讨

过去5年来

Across all phases of development, many indications and all pediatric age groups, we’ve been honored to serve as a CRO partner of choice for our biotech and pharmaceutical customers.

380

Pediatric projects in total

233

Rare disease projects involving pediatric populations

38

Advanced therapy projects (including cell and gene therapy) involving pediatric populations

Oncology & Hematology

Endocrinology & Metabolism

神经科学

传染病

Cardiovascular & Pulmonary

Get the latest updates from our pediatric experts.

We're sharing our latest news, events, and publications.

WHITE PAPER

Enrolling adolescents into adult clinical trials.

Read the white paper

We’re committed to bringing clinical research to all.

作为您的合作伙伴，我们可以作为您团队的补充：

Develop and execute your pediatric regulatory strategy and provide consulting to support your PIP and iPSP
Provide pediatric program development and study design including protocol writing
Enable custom strategy and planning for your program including feasibility, optimal country and site selection
Create relevant patient and family facing materials including assent/ consent for the different pediatric age groups
Collaborate with relevant advocacy groups, such as the International Children’s Advisory Network (iCAN)

作为您的敏捷合作伙伴，帮助开展复杂和新型的临床试验

Let our multidisciplinary experts put their experience to work to advance your pediatric drug development program and transform obstacles into opportunities. 通过合作，我们将提高您取得成功的潜力，并解决那些未得到满足的迫切的医疗需求。

探索我们相关的专业领域。

细胞和基因疗法罕见病我们的团队（RAPT）